E whakaatu ana i te
1 - 3
hua o te
3
Tīpoka ki te ihirangi
Takiuru
Reo
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Māori
Ngā āpure katoa
Taitara
Kaituhi
Marau
Tau karanga
ISBN/ISSN
Tūtohu
Kimi
Whatutoto
Kaituhi
Benjamin Wuest
Ngā hua rapu - Benjamin Wuest
E whakaatu ana i te
1 - 3
hua o te
3
Whakamahine hua
Kōmaka
Hāngaitanga
Rā heke iho
Rā piki ake
Tau karanga
Kaituhi
Taitara
1
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
mā
Celine Kaegi
,
Benjamin Wuest
,
Catherine Crowley
,
Onur Boyman
I whakaputaina 2022
Whiwhi kuputuhi katoa
Whiwhi kuputuhi katoa
Revisão
Tiaki ki tētahi rārangi
I tiakina i:
2
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
mā
Celine Kaegi
,
Urs C. Steiner
,
Benjamin Wuest
,
Catherine Crowley
,
Onur Boyman
I whakaputaina 2020
Whiwhi kuputuhi katoa
Whiwhi kuputuhi katoa
Artigo
Tiaki ki tētahi rārangi
I tiakina i:
3
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
mā
Celine Kaegi
,
Benjamin Wuest
,
Jens Schreiner
,
Urs C. Steiner
,
Alessandra Vultaggio
,
Andrea Matucci
,
Catherine Crowley
,
Onur Boyman
I whakaputaina 2019
Whiwhi kuputuhi katoa
Whiwhi kuputuhi katoa
Revisão
Tiaki ki tētahi rārangi
I tiakina i:
Ngā utauta rapu:
RSS Feed
Īmēratia tēnei rapu
Ngā marau whai pānga
Antibody
Immunology
Medicine
Etanercept
Internal medicine
Rheumatoid arthritis
Rituximab
Adverse effect
B cell
B-cell activating factor
Belimumab
CD20
Clinical trial
Dermatology
Immune system
Obinutuzumab
Ocrelizumab
Ofatumumab
Oncology
Please ensure Javascript is enabled for purposes of
website accessibility